VEMURAFENIB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where VEMURAFENIB was used for Prostate cancer.
Most Reported Side Effects for VEMURAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Rash | 1,202 | 14.0% | 52 | 239 |
| Arthralgia | 783 | 9.2% | 27 | 79 |
| Off label use | 782 | 9.1% | 90 | 120 |
| Fatigue | 773 | 9.0% | 37 | 122 |
| Diarrhoea | 655 | 7.7% | 51 | 225 |
| Nausea | 601 | 7.0% | 46 | 137 |
| Pyrexia | 569 | 6.7% | 33 | 299 |
| Death | 505 | 5.9% | 504 | 37 |
| Alopecia | 445 | 5.2% | 8 | 32 |
| Decreased appetite | 383 | 4.5% | 22 | 79 |
| Vomiting | 342 | 4.0% | 36 | 141 |
| No adverse event | 341 | 4.0% | 3 | 2 |
| Photosensitivity reaction | 321 | 3.8% | 20 | 64 |
| Pruritus | 305 | 3.6% | 13 | 54 |
| Sunburn | 292 | 3.4% | 7 | 24 |
Other Indications for VEMURAFENIB
Malignant melanoma (2,548)
Product used for unknown indication (2,079)
Metastatic malignant melanoma (1,848)
Hairy cell leukaemia (236)
Neoplasm malignant (188)
Langerhans' cell histiocytosis (146)
Thyroid cancer (119)
Colon cancer (110)
Erdheim-chester disease (108)
Malignant melanoma stage iv (88)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)